Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Select Medical Holdings (SEM) EBIAT (2018 - 2026)

Select Medical Holdings (SEM) has disclosed EBIAT for 9 consecutive years, with $44.0 million as the latest value for Q1 2026.

  • For Q1 2026, EBIAT fell 22.38% year-over-year to $44.0 million; the TTM value through Mar 2026 reached $166.5 million, up 0.86%, while the annual FY2025 figure was $214.5 million, 27.69% down from the prior year.
  • EBIAT hit $44.0 million in Q1 2026 for Select Medical Holdings, up from $37.7 million in the prior quarter.
  • Across five years, EBIAT topped out at $96.9 million in Q1 2024 and bottomed at -$175.3 million in Q4 2022.
  • Average EBIAT over 5 years is $35.1 million, with a median of $44.2 million recorded in 2025.
  • Year-over-year, EBIAT plummeted 451.58% in 2022 and then surged 460.96% in 2025.
  • Select Medical Holdings' EBIAT stood at -$175.3 million in 2022, then soared by 126.4% to $46.3 million in 2023, then crashed by 122.6% to -$10.5 million in 2024, then soared by 460.96% to $37.7 million in 2025, then rose by 16.57% to $44.0 million in 2026.
  • According to Business Quant data, EBIAT over the past three periods came in at $44.0 million, $37.7 million, and $44.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.